Healthcare Finance News October 13, 2023
Susan Morse

This year, 31 plans earned 5 stars, compared to 57 in 2023 and 74 in 2022.

The Centers for Medicare and Medicaid Services has released the Medicare Advantage, Part C and Medicare Part D Star Ratings that rank MA plans by the quality of health and drug services received by consumers.

Thirty-one contracts for both Medicare Advantage and the Part D drug plan earned 5 stars, compared to 57 in 2023.

Four contracts received the low overall ranking of 2 stars, the same as 2023.

Approximately 42% of MA-PD contracts that will be offered in 2024 earned 4 stars or higher for their 2024 overall rating. Weighted by enrollment, approximately 74% of MA-PD enrollees are currently in contracts that will...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Insurance, Medicare Advantage, Provider
Growth in Medicare Advantage Raises Concerns
Study reveals cost differences between Medicare Advantage and traditional Medicare patients in cancer drugs
CMS proposes $21B payment increase for Medicare Advantage in 2026: 10 notes
Medicare Advantage leads to lower cancer drug costs in colorectal cancer
A Stronger Medicare Program—Now And Into The Future

Share This Article